DK1459750T3
(en )
2005-08-15
(S, S) rebexetine for the treatment of fibromyalgia and other somatoform disorders
DK1047428T3
(en )
2007-10-08
Use of morpholinol in the treatment of sexual disorders
IS6560A
(en )
2002-09-20
Pharmaceutical composition for the treatment of acute, persistent pain and / or nervous system pain and migraine
DK1427437T3
(en )
2013-03-04
OXYNTOMODULIN FOR THE PREVENTION OR TREATMENT OF OVERWEIGHT
NO20004098L
(en )
2000-10-02
Methods and preparations for the treatment of macrophage-mediated disorders
DK1144395T3
(en )
2005-08-15
2-amino-benzoxazinone derivatives for the treatment of obesity
DK0967214T3
(en )
2004-09-27
Intranasal formulations for the treatment of sexual disorders
DK0966436T3
(en )
2003-03-31
Arylsulfonamides and analogs thereof and their use in the treatment of neurodegenerative disorders
IS8004A
(en )
2005-08-29
Method for the treatment of mild cognitive impairment and for the prevention or delay of Alzheimer's disease
DK1339406T3
(en )
2004-09-27
Piperazine derivatives, processes for their preparation and use thereof for the treatment of central nervous system disorders
NO20043085L
(en )
2004-07-13
Methods and compositions for the treatment of central nervous system disorders
ATE293447T1
(en )
2005-05-15
2-OXY-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF OBESITY
NO20054913D0
(en )
2005-10-24
Use of clustein for the treatment and / or prevention of peripheral neurological disorders
DK1228032T3
(en )
2004-11-01
Compositions containing hydroxyicosatetraenoic acid derivatives and methods for use in the treatment of eye disorders
DK0969845T3
(en )
2006-06-19
New therapeutic combinations of mirtazapine and antipsychotics for the treatment or prevention of psychotic disorders
NO20033443L
(en )
2003-09-30
Use of CD-2 binding agents in the treatment or prevention of skin disorders
DK199800837A
(en )
1999-12-30
Installations for the treatment of subjects
DK1041985T3
(en )
2006-06-19
Combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of prophylactic disorders
NO983512D0
(en )
1998-07-30
Means for the treatment and prevention of AIDS
ID27214A
(en )
2001-03-08
TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
DK1173179T3
(en )
2003-07-14
Use of saredutant and its pharmaceutically acceptable salts for the treatment or prevention of severe depressive disorder
DK1227827T3
(en )
2005-07-11
Lactic acid bacteria for the treatment and / or prevention of giardiasis
NO20012106D0
(en )
2001-04-27
Drug for the treatment of bone pathobolism
NO20013146D0
(en )
2001-06-22
Means for the treatment of visual cell dysfunction
DK1229906T3
(en )
2008-02-11
Mesoprogestins for the treatment and prevention of benign, hormone-dependent, gynecological disorders